FibroBiologics amends bylaws to reduce stockholder quorum to one-third of voting power

FibroBiologics, Inc.

Board amended Section 2.07 of Bylaws to lower quorum from majority to one-third of voting power.
Amendment adopted on April 16, 2026, and effective immediately.
No other material items reported in the filing.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

FibroBiologics, Inc.: Amended Section 2.07 of the Bylaws to reduce the quorum requirement for stockholder meetings from a majority of voting power to one-third of voting power (effective 2026-04-16).

Change: bylaw amendment
Effective: 2026-04-16

Exact text from the filing

On April 16, 2026, the board of directors (the “Board”) of FibroBiologics, Inc. (the “Company”) amended and restated the Company’s Amended and Restated Bylaws (the “Bylaws”) to amend Section 2.07 of the Bylaws to change the requirement for quorum at a meeting of the stockholders of the Company from a majority of voting power to one-third of the voting power (the “Amendment”).

View on SEC.gov

102 governance changes filed in the last 30 days. Browse all governance changes →

FibroBiologics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-161507

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.